drugset / Trial / NCT02632747
Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study
RandomizedCrossoverDouble-blindTreatment
Summary
This is a randomized, double-blind, double-dummy, placebo-controlled, cross over design trial with empagliflozin compared to placebo that is added to open-label ramipril.
Timeline
- Start
- 2016-05-10
- Primary completion
- 2017-12-19
- Completion
- 2019-07-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 25 mg | — |
| Background | Ramipril | Small molecule | 10 mg | — |